Organization
Washington University School of Medicine in St. Louis, St. Louis, MO
3 abstracts
Abstract
Metabolic disorders in patients diagnosed with colorectal cancer.Org: Department of Internal Medicine, Oregon Health & Science University, Portland, OR, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, Department of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Heidelberg, Germany, Fred Hutchinson Cancer Research Center, Seattle, WA, Department of Surgery, The University of Tennessee, Memphis, TN,
Abstract
Pelabresib (CPI-0610) monotherapy in high-risk essential thrombocythemia refractory or intolerant to hydroxyurea: Preliminary results from MANIFEST study.Org: University of Insubria, Varese, Italy, Hematology Unit, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy, Department of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom, Mayo Clinic Florida, Jacksonville, FL, The Richard T. Silver, M.D. Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Cornell Medicine, New York, NY,
Abstract
The changing landscape of small-cell lung cancer.Org: Division of Oncology, Washington University in St. Louis School of Medicine, Saint Louis, MO, Washington University School of Medicine, St. Louis, MO, Thomas Jefferson University, Philadelphia, PA, Washington University School of Medicine in St. Louis, St. Louis, MO, Duke Cancer Institute, Duke University School of Medicine, Durham, NC,